Immune-Mediated Inflammatory Diseases Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Targeted biologic therapies
1.2.3 Novel therapies
1.3 Market by Application
1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2018-2030)
2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Region
2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2018-2023)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2023-2030)
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends
2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2018-2023)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2022
3.5 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
3.7 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2018-2023)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2023-2030)
5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2018-2023)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2030)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023)
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2030)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023)
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2030)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023)
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2030)
9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023)
9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2018-2030)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023)
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Detail
11.4.2 Bristol-Myers Business Overview
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.4.5 Bristol-Myers Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Detail
11.7.2 Enlivex Therapeutics Business Overview
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.7.5 Enlivex Therapeutics Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Detail
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.8.5 Immune Pharmaceuticals Recent Development
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Detail
11.9.2 Tanabe Pharma Business Overview
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
11.9.5 Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Targeted biologic therapies
Table 3. Key Players of Novel therapies
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2018-2023)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2023-2030)
Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2018-2023)
Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2022)
Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
Table 21. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2023-2030)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2023-2030)
Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 33. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 35. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2023-2030) & (US$ Million)
Table 37. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 39. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2023-2030) & (US$ Million)
Table 41. GlaxoSmithKline Company Detail
Table 42. GlaxoSmithKline Business Overview
Table 43. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
Table 44. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 45. GlaxoSmithKline Recent Development
Table 46. Eli Lilly Company Detail
Table 47. Eli Lilly Business Overview
Table 48. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
Table 49. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 50. Eli Lilly Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
Table 54. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Bristol-Myers Company Detail
Table 57. Bristol-Myers Business Overview
Table 58. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
Table 59. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
Table 64. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Immune-Mediated Inflammatory Diseases Treatment Product
Table 69. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Enlivex Therapeutics Company Detail
Table 72. Enlivex Therapeutics Business Overview
Table 73. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
Table 74. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 75. Enlivex Therapeutics Recent Development
Table 76. Immune Pharmaceuticals Company Detail
Table 77. Immune Pharmaceuticals Business Overview
Table 78. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product
Table 79. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 80. Immune Pharmaceuticals Recent Development
Table 81. Tanabe Pharma Company Detail
Table 82. Tanabe Pharma Business Overview
Table 83. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
Table 84. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023) & (US$ Million)
Table 85. Tanabe Pharma Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2022 VS 2030
Figure 2. Targeted biologic therapies Features
Figure 3. Novel therapies Features
Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application in 2022 & 2030
Figure 5. Hospitals Case Studies
Figure 6. Pharmacy Store Case Studies
Figure 7. Online Pharmacy Stroe Case Studies
Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region: 2022 VS 2030
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2022
Figure 13. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2022
Figure 15. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 16. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2018-2030)
Figure 17. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 18. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 19. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 20. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2018-2030)
Figure 21. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2018-2030)
Figure 29. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2018-2030)
Figure 37. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2018-2030)
Figure 41. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 44. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 45. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 46. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 49. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 50. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 51. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Industry Market Size
